119 related articles for article (PubMed ID: 26568378)
1. New investigations into the stability of Mesna using LC-MS/MS and NMR.
Salman D; Swinden J; Peron JM; Barton S; Nabhani-Gebara S
Expert Rev Anticancer Ther; 2016; 16(1):123-30. PubMed ID: 26568378
[TBL] [Abstract][Full Text] [Related]
2. The stability of mesna in beverages and syrup for oral administration.
Goren MP; Lyman BA; Li JT
Cancer Chemother Pharmacol; 1991; 28(4):298-301. PubMed ID: 1908750
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of mesna and dimesna after simultaneous intravenous bolus and infusion administration in patients undergoing bone marrow transplantation.
el-Yazigi A; Ernst P; al-Rawithi S; Legayada E; Raines DA
J Clin Pharmacol; 1997 Jul; 37(7):618-24. PubMed ID: 9243355
[TBL] [Abstract][Full Text] [Related]
4. Reduction of dimesna to mesna by the isolated perfused rat liver.
Goren MP; Hsu LC; Li JT
Cancer Res; 1998 Oct; 58(19):4358-62. PubMed ID: 9766664
[TBL] [Abstract][Full Text] [Related]
5. Physical and chemical stability of high-dose ifosfamide and mesna for prolonged 14-day continuous infusion.
Zhang Y; Kawedia JD; Myers AL; McIntyre CM; Anderson PM; Kramer MA; Culotta KS
J Oncol Pharm Pract; 2014 Feb; 20(1):51-7. PubMed ID: 23512269
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatographic analysis of mesna and dimesna in plasma and urine of patients treated with mesna.
el-Yazigi A; Yusuf A; al-Rawithi S
Ther Drug Monit; 1995 Apr; 17(2):153-8. PubMed ID: 7624904
[TBL] [Abstract][Full Text] [Related]
7. Structural analysis of photo-degradation in thiazole-containing compounds by LC-MS/MS and NMR.
Wu L; Hong TY; Vogt FG
J Pharm Biomed Anal; 2007 Jul; 44(3):763-72. PubMed ID: 17442527
[TBL] [Abstract][Full Text] [Related]
8. Vibrational spectroscopic studies of mesna and dimesna.
Li YS; Wang Y; Church JS; Garzena F; Zhang Z; An D
Spectrochim Acta A Mol Biomol Spectrosc; 2003 Jun; 59(8):1791-8. PubMed ID: 12736065
[TBL] [Abstract][Full Text] [Related]
9. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
[TBL] [Abstract][Full Text] [Related]
10. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy.
Kurowski V; Wagner T
Cancer Chemother Pharmacol; 1997; 39(5):431-9. PubMed ID: 9054957
[TBL] [Abstract][Full Text] [Related]
12. Identification of chemical constituents in two traditional Chinese medicine formulae by liquid chromatography-mass spectrometry and off-line nuclear magnetic resonance.
Wang S; Zhu Y; Shao Q; Wang Y; Fan X; Cheng Y
J Pharm Biomed Anal; 2016 Jan; 117():255-65. PubMed ID: 26397205
[TBL] [Abstract][Full Text] [Related]
13. Dithio-bis-mercaptoethanesulphonate (DIMESNA) does not prevent cellular damage by metabolites of ifosfamide and cyclophosphamide in LLC-PK1 cells.
Mohrmann M; Ansorge S; Schönfeld B; Brandis M
Pediatr Nephrol; 1994 Aug; 8(4):458-65. PubMed ID: 7524598
[TBL] [Abstract][Full Text] [Related]
14. Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects.
Goren MP; Houle JM; Bush DA; Li JT; Newman CE; Brade WP
Clin Cancer Res; 1998 Oct; 4(10):2313-20. PubMed ID: 9796960
[TBL] [Abstract][Full Text] [Related]
15. Degradation kinetics study of cabozantinib by a novel stability-indicating LC method and identification of its major degradation products by LC/TOF-MS and LC-MS/MS.
Wu C; Xu X; Feng C; Shi Y; Liu W; Zhu X; Zhang J
J Pharm Biomed Anal; 2014 Sep; 98():356-63. PubMed ID: 24992215
[TBL] [Abstract][Full Text] [Related]
16. Identification and structural characterization of hydrolytic degradation products of alvimopan by LC/QTOF/MS/MS and NMR studies.
Baira SM; R S; Talluri MVNK
J Pharm Biomed Anal; 2019 Feb; 165():399-409. PubMed ID: 30590338
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the stability profile of anticancer drugs: A review of Ifosfamide and Mesna regimen for the treatment of metastatic soft tissue sarcoma.
Salman D; Swinden J; Barton S; Peron JM; Nabhani-Gebara S
J Oncol Pharm Pract; 2016 Feb; 22(1):86-91. PubMed ID: 25178698
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of 2-mercaptoethanesulfonic acid albumin.
Bauer HH; Ehmig S; Engels JW; Voelcker G
Arzneimittelforschung; 1998 Jun; 48(6):691-3. PubMed ID: 9689429
[TBL] [Abstract][Full Text] [Related]
19. Identification of degradation products in loxoprofen sodium adhesive tapes by liquid chromatography-mass spectrometry and dynamic pressurized liquid extraction-solid-phase extraction coupled to liquid chromatography-nuclear magnetic resonance spectroscopy.
Murakami T; Kawasaki T; Takemura A; Fukutsu N; Kishi N; Kusu F
J Chromatogr A; 2008 Oct; 1208(1-2):164-74. PubMed ID: 18778828
[TBL] [Abstract][Full Text] [Related]
20. Determination and characterization of degradation products of anastrozole by LC-MS/MS and NMR spectroscopy.
Sitaram C; Rupakula R; Reddy BN
J Pharm Biomed Anal; 2011 Dec; 56(5):962-8. PubMed ID: 21890298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
